Zenosense, Inc.’s (ZENO) Heart Attack Testing Technology Development Continues to Advance Hopes of Portable Point of Care Device
Company’s MIDS Cardiac device aims to help ER personnel perform quick, high-sensitivity analysis of heart events MIDS device’s handheld portability is being developed to allow quick-response resource to minimally trained ambulance personnel Final device could ultimately help save patients, health insurers from unnecessary evaluation expenses Heart disease remains the leading cause of death in men and women within the United States (http://ibn.fm/iTWKf), accounting for one out of every four deaths, and, as such, is fertile ground for research that is published regularly in professional periodicals such as the Journal of the American Heart Association (http://ibn.fm/xrAJK). The ailment is also the inspiration for…